{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:14:59Z","timestamp":1787962499369,"version":"build-2784847793"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81971302 and No.81771494"],"award-info":[{"award-number":["No.81971302 and No.81771494"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prevalence of ischaemic heart failure (HF) continues to increase. Diabetes mellitus (DM) concomitant with ischaemic HF increases the risk of major adverse cardiovascular events (MACEs). As a promising predictor for cardiovascular diseases, the predictive value of the monocyte to high-density lipoprotein cholesterol ratio (MHR) for MACE in the ischaemic HF with DM cohort has never been investigated before.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>We aimed to investigate the MHR as a predictor for MACE in ischaemic HF patients with DM who underwent percutaneous coronary intervention (PCI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This observational study enrolled 1049 patients with ischaemic HF and DM undergoing PCI from June 2017 to June 2019. The baseline data were collected. MACEs, including all-cause mortality, nonfatal myocardial infarction, and any revascularization, were recorded within the 36-month follow-up. The characteristics and incidence of MACE were analysed in four groups stratified by the quartiles of MHR. The hazard ratio for MACE was analysed with Cox regression models. The incidence of MACE in the four groups was evaluated by Kaplan\u2012Meier survival analysis. Restricted cubic spline analysis was performed to determine the nonlinear correlation between the MHR and MACE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After the 36-month follow-up, 407 patients (38.8%) experienced MACEs. The incidence of MACE was significantly higher among patients in the upper MHR quartile than among those in the lower MHR quartiles (23.4% vs. 36.0% vs. 41.4% and 54.6%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, respectively), which was consistent with the Kaplan\u2012Meier survival analyses (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). A multivariate Cox regression model showed that the MHR was an independent risk factor for MACE after variables were adjusted (adjusted HR: 2.11; 95% CI 1.47\u20133.03; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Its predictive effects on MACE showed no interaction with hypercholesterolemia (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The MHR was a significant and independent predictor of MACEs in ischaemic HF patients with DM undergoing PCI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01451-6","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T05:01:48Z","timestamp":1699419708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: a retrospective study"],"prefix":"10.1186","volume":"28","author":[{"given":"Qiuyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuguang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"issue":"7","key":"1451_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jchf.2020.01.014","volume":"8","author":"LK Truby","year":"2020","unstructured":"Truby LK, Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. JACC Heart Fail. 2020;8(7):523\u201336.","journal-title":"JACC Heart Fail"},{"issue":"10","key":"1451_CR2","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"VL Roger","year":"2021","unstructured":"Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128(10):1421\u201334.","journal-title":"Circ Res"},{"issue":"2","key":"1451_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams Jr","year":"2005","unstructured":"Adams KF Jr, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209\u201316.","journal-title":"Am Heart J"},{"issue":"3","key":"1451_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10741-018-9672-5","volume":"23","author":"YMF Chia","year":"2018","unstructured":"Chia YMF, et al. Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure. Heart Fail Rev. 2018;23(3):461\u20138.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"1451_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cpcardiol.2014.09.002","volume":"40","author":"A Dei Cas","year":"2015","unstructured":"Dei Cas A, et al. Concomitant diabetes mellitus and heart failure. Curr Probl Cardiol. 2015;40(1):7\u201343.","journal-title":"Curr Probl Cardiol"},{"issue":"7","key":"1451_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.amjmed.2006.05.024","volume":"119","author":"AM From","year":"2006","unstructured":"From AM, et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med. 2006;119(7):591\u20139.","journal-title":"Am J Med"},{"issue":"5","key":"1451_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","volume":"24","author":"JG Cleland","year":"2003","unstructured":"Cleland JG, et al. The EuroHeart Failure survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24(5):442\u201363.","journal-title":"Eur Heart J"},{"issue":"24","key":"1451_CR8","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","volume":"138","author":"DA McAllister","year":"2018","unstructured":"McAllister DA, et al. Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus. Circulation. 2018;138(24):2774\u201386.","journal-title":"Circulation"},{"issue":"19","key":"1451_CR9","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease The Framingham study. JAMA. 1979;241(19):2035\u20138.","journal-title":"JAMA"},{"issue":"18","key":"1451_CR10","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.jacc.2007.12.048","volume":"51","author":"H Bahrami","year":"2008","unstructured":"Bahrami H, et al. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol. 2008;51(18):1775\u201383.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1451_CR11","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","volume":"35","author":"JS Gottdiener","year":"2000","unstructured":"Gottdiener JS, et al. Predictors of congestive heart failure in the elderly: the Cardiovasc Health Study. J Am Coll Cardiol. 2000;35(6):1628\u201337.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1451_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ejhf.679","volume":"19","author":"G Targher","year":"2017","unstructured":"Targher G, et al. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(1):54\u201365.","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"1451_CR13","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.jacc.2016.06.061","volume":"68","author":"I Johansson","year":"2016","unstructured":"Johansson I, et al. Prognostic implications of type 2 diabetes mellitus in ischemic and nonischemic heart failure. J Am Coll Cardiol. 2016;68(13):1404\u201316.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1451_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ahj.2015.06.013","volume":"170","author":"MA Daubert","year":"2015","unstructured":"Daubert MA, et al. High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction. Am Heart J. 2015;170(3):550\u20138.","journal-title":"Am Heart J"},{"issue":"2","key":"1451_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.amjcard.2010.03.014","volume":"106","author":"SG Sawada","year":"2010","unstructured":"Sawada SG, et al. Effect of revascularization on long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability. Am J Cardiol. 2010;106(2):187\u201392.","journal-title":"Am J Cardiol"},{"issue":"6","key":"1451_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jchf.2018.01.024","volume":"6","author":"D Perera","year":"2018","unstructured":"Perera D, et al. Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial: percutaneous coronary intervention for ischemic cardiomyopathy. JACC Heart Fail. 2018;6(6):517\u201326.","journal-title":"JACC Heart Fail"},{"issue":"15","key":"1451_CR17","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","volume":"387","author":"D Perera","year":"2022","unstructured":"Perera D, et al. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022;387(15):1351\u201360.","journal-title":"N Engl J Med"},{"issue":"12","key":"1451_CR18","doi-asserted-by":"publisher","first-page":"9237","DOI":"10.1002\/jcp.27028","volume":"233","author":"S Ganjali","year":"2018","unstructured":"Ganjali S, et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018;233(12):9237\u201346.","journal-title":"J Cell Physiol"},{"issue":"2","key":"1451_CR19","first-page":"104","volume":"74","author":"F Eyyupkoca","year":"2022","unstructured":"Eyyupkoca F, et al. Admission monocyte\/HDL ratio predicts adverse cardiac remodeling after St-elevation myocardial infarction. Rev Invest Clin. 2022;74(2):104\u201312.","journal-title":"Rev Invest Clin"},{"issue":"3","key":"1451_CR20","doi-asserted-by":"publisher","first-page":"885","DOI":"10.12669\/pjms.37.3.3469","volume":"37","author":"R Yu","year":"2021","unstructured":"Yu R, et al. Correlation between monocyte to high-density lipoprotein ratio and major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Pak J Med Sci. 2021;37(3):885\u20139.","journal-title":"Pak J Med Sci"},{"issue":"8","key":"1451_CR21","doi-asserted-by":"publisher","first-page":"BSR20201108","DOI":"10.1042\/BSR20201108","volume":"40","author":"DP Zhang","year":"2020","unstructured":"Zhang DP, et al. An elevated monocyte-to-high-density lipoprotein-cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI. Biosci Rep. 2020;40(8):BSR20201108.","journal-title":"Biosci Rep"},{"issue":"3","key":"1451_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.repc.2017.06.021","volume":"37","author":"A Sercelik","year":"2018","unstructured":"Sercelik A, et al. Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment elevation myocardial infarction. Rev Port Cardiol (Engl Ed). 2018;37(3):217\u201323.","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"5","key":"1451_CR23","doi-asserted-by":"publisher","first-page":"e13973","DOI":"10.1111\/ijcp.13973","volume":"75","author":"M Oylumlu","year":"2021","unstructured":"Oylumlu M, et al. Monocyte to high-density lipoprotein cholesterol and lymphocyte to monocyte ratios are predictors of in-hospital and long-term mortality in patients with acute coronary syndrome. Int J Clin Pract. 2021;75(5):e13973.","journal-title":"Int J Clin Pract"},{"issue":"21","key":"1451_CR24","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.21037\/atm-21-4876","volume":"9","author":"C Li","year":"2021","unstructured":"Li C, et al. The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome. Ann Transl Med. 2021;9(21):1627.","journal-title":"Ann Transl Med"},{"issue":"1","key":"1451_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-020-01242-6","volume":"19","author":"DLE Villanueva","year":"2020","unstructured":"Villanueva DLE, et al. Monocyte to high-density lipoprotein ratio (MHR) as a predictor of mortality and major adverse cardiovascular events (MACE) among ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids Health Dis. 2020;19(1):55.","journal-title":"Lipids Health Dis"},{"issue":"33","key":"1451_CR26","doi-asserted-by":"publisher","first-page":"e30109","DOI":"10.1097\/MD.0000000000030109","volume":"101","author":"HT Liu","year":"2022","unstructured":"Liu HT, et al. Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: a meta-analysis of 9 studies. Medicine (Baltimore). 2022;101(33):e30109.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"1451_CR27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.amjms.2020.01.018","volume":"359","author":"M Sun","year":"2020","unstructured":"Sun M, et al. Prognostic utility of monocyte to high-density lipoprotein ratio in patients with acute coronary syndrome: a meta-analysis. Am J Med Sci. 2020;359(5):281\u20136.","journal-title":"Am J Med Sci"},{"issue":"10","key":"1451_CR28","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.3390\/medicina58101473","volume":"58","author":"R Wang","year":"2022","unstructured":"Wang R, et al. Application value of systemic inflammatory indexes in the clinical evaluation of patients with heart failure with preserved ejection fraction (HFpEF). Medicina (Kaunas). 2022;58(10):1473.","journal-title":"Medicina (Kaunas)"},{"key":"1451_CR29","doi-asserted-by":"publisher","first-page":"100056","DOI":"10.1016\/j.clinsp.2022.100056","volume":"77","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. Associations of systemic inflammatory markers with the risks of chronic heart failure: a case-control study. Clinics (Sao Paulo). 2022;77:100056.","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"1451_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1536\/ihj.21-681","volume":"63","author":"J Zhong","year":"2022","unstructured":"Zhong J, et al. Monocyte to high-density lipoprotein cholesterol ratio is associated with subclinical left cardiac remodeling and dysfunction in type 2 diabetes mellitus. Int Heart J. 2022;63(3):524\u201330.","journal-title":"Int Heart J"},{"issue":"1","key":"1451_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12872-021-02180-6","volume":"21","author":"DS Mayasari","year":"2021","unstructured":"Mayasari DS, et al. Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes. BMC Cardiovasc Disord. 2021;21(1):362.","journal-title":"BMC Cardiovasc Disord"},{"issue":"27","key":"1451_CR32","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/eurheartj\/ehab273","volume":"42","author":"S V\u00f6lz","year":"2021","unstructured":"V\u00f6lz S, et al. Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2021;42(27):2657\u201364.","journal-title":"Eur Heart J"},{"issue":"24","key":"1451_CR33","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","volume":"63","author":"F Alfonso","year":"2014","unstructured":"Alfonso F, et al. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014;63(24):2659\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1451_CR34","first-page":"219","volume":"1","author":"G Sianos","year":"2005","unstructured":"Sianos G, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219\u201327.","journal-title":"EuroIntervention"},{"issue":"4","key":"1451_CR35","first-page":"349","volume":"50","author":"Chinese Society of Cardiology","year":"2022","unstructured":"Chinese Society of Cardiology, Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Chinese guideline for percutaneous coronary intervention in patients with left main bifurcation disease. Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50(4):349\u201360.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"18","key":"1451_CR36","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"10204","key":"1451_CR37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;394(10204):1145\u201358.","journal-title":"Lancet"},{"issue":"19","key":"1451_CR38","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1161\/CIR.0000000000000095","volume":"130","author":"SD Fihn","year":"2014","unstructured":"Fihn SD, et al. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2014;130(19):1749\u201367.","journal-title":"Circulation"},{"issue":"1","key":"1451_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/ATVBAHA.116.308198","volume":"37","author":"RM Kratofil","year":"2017","unstructured":"Kratofil RM, et al. Monocyte conversion during inflammation and injury. Arterioscler Thromb Vasc Biol. 2017;37(1):35\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"1451_CR40","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","volume":"118","author":"I Tabas","year":"2016","unstructured":"Tabas I, et al. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118(4):653\u201367.","journal-title":"Circ Res"},{"issue":"3","key":"1451_CR41","doi-asserted-by":"publisher","first-page":"e1400223","DOI":"10.1126\/sciadv.1400223","volume":"1","author":"J Tang","year":"2015","unstructured":"Tang J, et al. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci Adv. 2015;1(3):e1400223.","journal-title":"Sci Adv"},{"issue":"7","key":"1451_CR42","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1440-1681.2009.05338.x","volume":"37","author":"AJ Murphy","year":"2010","unstructured":"Murphy AJ, et al. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol. 2010;37(7):710\u20138.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"1451_CR43","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","volume":"95","author":"PJ Barter","year":"2004","unstructured":"Barter PJ, et al. Antiinflammatory properties of HDL. Circ Res. 2004;95(8):764\u201372.","journal-title":"Circ Res"},{"issue":"2","key":"1451_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/0003319719854609","volume":"71","author":"E Xepapadaki","year":"2020","unstructured":"Xepapadaki E, et al. \u03a4he antioxidant function of HDL in atherosclerosis. Angiology. 2020;71(2):112\u201321.","journal-title":"Angiology"},{"issue":"14","key":"1451_CR45","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.7150\/ijms.47998","volume":"17","author":"Y Xiang","year":"2020","unstructured":"Xiang Y, et al. Lower HDL-C levels are associated with higher expressions of CD16 on monocyte subsets in coronary atherosclerosis. Int J Med Sci. 2020;17(14):2171\u20139.","journal-title":"Int J Med Sci"},{"key":"1451_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.addr.2020.10.006","volume":"159","author":"S Nazir","year":"2020","unstructured":"Nazir S, et al. Interaction between high-density lipoproteins and inflammation: Function matters more than concentration! Adv Drug Deliv Rev. 2020;159:94\u2013119.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9943","key":"1451_CR47","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"DJ Rader","year":"2014","unstructured":"Rader DJ, et al. HDL and cardiovascular disease. Lancet. 2014;384(9943):618\u201325.","journal-title":"Lancet"},{"issue":"3","key":"1451_CR48","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/MCA.0000000000000343","volume":"27","author":"G \u00c7i\u00e7ek","year":"2016","unstructured":"\u00c7i\u00e7ek G, et al. The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI. Coron Artery Dis. 2016;27(3):176\u201384.","journal-title":"Coron Artery Dis"},{"issue":"2","key":"1451_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ajem.2015.10.049","volume":"34","author":"MB Karata\u015f","year":"2016","unstructured":"Karata\u015f MB, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016;34(2):240\u20134.","journal-title":"Am J Emerg Med"},{"issue":"5","key":"1451_CR50","first-page":"505","volume":"23","author":"SK A\u00e7\u0131kg\u00f6z","year":"2016","unstructured":"A\u00e7\u0131kg\u00f6z SK, et al. Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction. Cardiol J. 2016;23(5):505\u201312.","journal-title":"Cardiol J"},{"issue":"5","key":"1451_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/07853890.2016.1168935","volume":"48","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med. 2016;48(5):305\u201312.","journal-title":"Ann Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01451-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01451-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T06:04:24Z","timestamp":1699423464000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01451-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1451"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01451-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Beijing Anzhen Hospital, Beijing, China, approved this study. Informed consent was obtained from all participants in this analysis. All procedures performed in this study involving human participants were in accordance with the Declaration of Helsinki (No. 2022235X).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"493"}}